Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Jai Moo Shin"'
Publikováno v:
Molecules, Vol 14, Iss 12, Pp 5247-5280 (2009)
New arylsulfonyl proton pump inhibitor (PPI) prodrug forms were synthesized. These prodrugs provided longer residence time of an effective PPI plasma concentration, resulting in better gastric acid inhibition.
Externí odkaz:
https://doaj.org/article/c18a37f4c6b648fe8db80fd42c640d25
Autor:
Jai Moo Shin1 jaishin@ucla.edu, Wallmark, Björn2 bjoern.wallmark@schering.de, Sachs, George1 gsachs@ucla.edu
Publikováno v:
Encyclopedic Reference of Molecular Pharmacology. 2004, p771-774. 4p.
Autor:
Jai Moo Shin1 jaimooshin@gmail.com, Nayoung Kim2,3
Publikováno v:
Journal of Neurogastroenterology & Motility. Jan2013, Vol. 19 Issue 1, p25-35. 11p.
Autor:
Jai Moo Shin1, Sachs, George1, Young-moon Cho1 ymkscho@yahoo.com, Garst, Michael2 garstmichael@allergan.com
Publikováno v:
Molecules. Dec2009, Vol. 14 Issue 12, p5247-5280. 34p. 6 Diagrams, 1 Chart.
Autor:
Nayoung Kim, Jai Moo Shin
Publikováno v:
Journal of Neurogastroenterology and Motility
Proton pump inhibitor (PPI) is a prodrug which is activated by acid. Activated PPI binds covalently to the gastric H(+), K(+)-ATPase via disulfide bond. Cys813 is the primary site responsible for the inhibition of acid pump enzyme, where PPIs bind. O
Publikováno v:
Current Gastroenterology Reports
Sachs, George; Shin, Jai Moo; & Hunt, Richard. (2010). Novel Approaches to Inhibition of Gastric Acid Secretion. Current Gastroenterology Reports, 12(6), pp 437-447. doi: 10.1007/s11894-010-0149-5. Retrieved from: http://www.escholarship.org/uc/item/6319s54m
Sachs, George; Shin, Jai Moo; & Hunt, Richard. (2010). Novel Approaches to Inhibition of Gastric Acid Secretion. Current Gastroenterology Reports, 12(6), pp 437-447. doi: 10.1007/s11894-010-0149-5. Retrieved from: http://www.escholarship.org/uc/item/6319s54m
The gastric H,K-adenosine triphosphatase (ATPase) is the primary target for treatment of acid-related diseases. Proton pump inhibitors (PPIs) are weak bases composed of two moieties, a substituted pyridine with a primary pK(a) of about 4.0 that allow
Autor:
George Sachs, Jai Moo Shin
Publikováno v:
Current Gastroenterology Reports. 10:528-534
The gastric H,K-ATPase is the primary target for the treatment of acid-related diseases. Proton pump inhibitors (PPIs) are weak bases composed of two moieties, a substituted pyridine with a primary pK(a) of about 4.0, which allows selective accumulat
Publikováno v:
Pflügers Archiv - European Journal of Physiology. 457:609-622
The gastric H,K-ATPase, a member of the P(2)-type ATPase family, is the integral membrane protein responsible for gastric acid secretion. It is an alpha,beta-heterodimeric enzyme that exchanges cytoplasmic hydronium with extracellular potassium. The
Publikováno v:
Cellular and Molecular Life Sciences. 65:264-281
Inhibition of gastric acid secretion is the mainstay of the treatment of gastroesophageal reflux disease and peptic ulceration; therapies to inhibit acid are among the best-selling drugs worldwide. Highly effective agents targeting the histamine H2 r
Publikováno v:
Biochemistry. 44:16321-16332
Cross-linking and two-dimensional crystallization studies have suggested that the membrane-bound gastric H,K-ATPase might be a dimeric alpha,beta-heterodimer. Effects of an oligomeric structure on the characteristics of E(1), E(2), and phosphoenzyme